SPONSOR
Bavarian Nordic
Total Trials
2
Recruiting
2
Phases
Phase 3
Conditions studied: Chikungunya Virus
Bavarian Nordic is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Chikungunya Virus.
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Bavarian Nordic
How many clinical trials has Bavarian Nordic sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Bavarian Nordic, of which 2 are actively recruiting participants. These trials cover conditions including Chikungunya Virus. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Bavarian Nordic research focus on?
Bavarian Nordic clinical trials span Chikungunya Virus. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Bavarian Nordic clinical trial?
To participate in a Bavarian Nordic trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Bavarian Nordic trials with current recruitment status updated daily.
Clinical Trials by Bavarian Nordic
NCT07467707 Phase 3
Recruiting
An Efficacy, Safety, and Immunogenicity Study of CHIKV VLP Vaccine for the Prevention of Chikungunya Disease in Adolescents and Adults
Chikungunya Virus
NCT07003984 Phase 3
Recruiting
A Safety and Immunogenicity Study of CHIKV VLP Vaccine in Children.
Chikungunya Virus
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology